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Disruption in circadian rhythms either by mutation in mice or by shiftwork in people, is associated
with an increased risk for the development of multiple organ diseases. In turn, organ disease may
inﬂuence the function of clock genes and peripheral circadian systems. Here we showed that hepatic
ﬁbrosis induced by carbon tetrachloride in mice leads to alterations in the circadian rhythms of
hepatic clock genes. Especially, we found an impaired daily Cry2 rhythm in the ﬁbrotic livers, with
markedly decreased levels during the day time while compared with control livers. Associatively,
the expressions of two important clock-regulated genes peroxisome proliferator-activated receptor
alpha and cytochrome P450 oxidoreductase lost circadian rhythm with signiﬁcantly decreased lev-
els during the light–dark (12/12 h) cycle in ﬁbrotic livers.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Circadian rhythms are daily cycles of physiology and behaviour
which are driven by an endogenous oscillator with a period of
approximately one day [1–3]. A broad spectrum of physiological
parameters including the sleep–wake cycle, hormone secretion,
heart beat, blood ﬂow and body temperature ﬂuctuate with a per-
iod of 24 h [4]. In mammals, the master circadian clock is located in
the suprachiasmatic nuclei (SCN) [5], and the peripheral circadian
oscillator also exists in several organs including liver. Disruption in
circadian rhythms either by mutation in mice or by shiftwork in
people, is associated with an increased risk for the development
of multiple organ diseases [6,7]. In turn, a lot of pathological pro-
cesses such as Alzheimer’s disease, obesity/type-2 diabetes and
hypertension inﬂuence the circadian expressions of clock genes
in peripheral tissue [8–10].
As the ﬁnal common pathway of most chronic liver diseases
[11], liver ﬁbrosis which leads eventually to cirrhosis and hepato-
cellular carcinoma is the major causes of morbidity and mortalitychemical Societies. Published by E
epatic stellate cell; a-SMA,
cle Arnt-like protein 1; Per,
ei; ZT, zeitgeber time; PPARa,
; POR, cytochrome P450
g).worldwide [12,13]. It is reported that a variety of circadian param-
eters, including ﬁbribolysis [14], variceal bleeding [15], heptatic
catabolism of melatonin and plasma melatonin [16,17], arterial
blood pressure and heart rate [18,19], gastric acidity [20] and even
sleep [21,22] are disrupted in cirrhosis patients or mice. In view of
the reality that altered circadian rhythms of physiological parame-
ters are observed in cirrhosis patients, it is of interest to explore the
relationship between liver ﬁbrogenesis and hepatic circadian clock
genes expression. In the present study, we compared the expres-
sions of hepatic circadian clock genes and two important clock-
regulated hepatic metabolic genes, peroxisome proliferator-acti-
vated receptor alpha (PPARa) and cytochrome P450 oxidoreductase
(POR), to explore the impact of ﬁbrogenesis on hepatic circadian
system.
2. Materials and methods
2.1. Animals
Male 7–8 week old C57BL/6 mice were used in this work.
Animals were maintained in 12/12 h light/dark cycles with light
on at 7:00 am and off at 7:00 pm, and with free access to reg-
ular chow food and water. All animal care and use procedures
were in accordance with the guidelines of the Institutional Ani-
mal Care and Use Committee at Nanjing University of Science
and Technology.lsevier B.V. All rights reserved.
Table 1
Primer sequences used for real-time PCR.
Gene Forward/
Reverse
Primer (50–30)
Gapdh Forward
Reverse
CATCCACTGGTGCTGCC AAGGCTGT
ACAACCTGGTCCTCAGTGTAGCCCA
Bmal1 Forward
Reverse
ACATAGGACACCTCGCAGAA
AACCATCGACTTCGTAGCGT
Clock Forward
Reverse
CGGCGAGAACTTGGCATT
AGGAGTTGGGCTGTGATCA
Per1 Forward
Reverse
TCCTCAACCGCTTCAGAGATC
CGGGAACGCTTTGCTTTAGA
Per2 Forward
Reverse
GTGAAGCAGGTGAAGGCTAAT
AAGCTTGTAAGGGGTGGTGTAG
Cry1 Forward
Reverse
TTGCCTGTTTCCTGACTCGT
GACAGCCACATCCAACTTCC
Cry2 Forward
Reverse
TCGGCTCAACATTGAACGAA
GGGCCACTGGATAGTGCTCT
PPARa Forward
Reverse
GGGTACCACTACGGAGTTCACG
CAGACAGGCACTTGTGAAAACG
POR Forward
Reverse
GAAGAGCTACGAGAACCAG
TCAGGTACAGCTCCTTGC
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Hepatic ﬁbrosis was induced by intraperitoneal injection of
0.6 ml/kg of body weight of carbon tetrachloride (CCl4) which
was diluted in olive oil twice-a-week for 4 weeks and control
group received the same volume of vehicle [23]. One day after
the last injection mice (without fasting) were sacriﬁced at zeitge-Fig. 1. Representative images of Masson’s trichome staining and a-SMA immunohistoch
olive oil and CCl4. The collagen deposition showed in blue was markedly observed in ﬁb
immunohistochemistry, in control mice, very weak positive response exists (C) while i
100.ber time1 (ZT1) (ZT0 corresponds lights on and ZT12 to light off),
ZT5, ZT9, ZT13, ZT17, ZT21 (n = 5–6, each time point).
2.3. Histological analyses and immunohistochemistry
A small piece of liver tissue was collected and ﬁxed in 10% buf-
fered formalin. The sample was then embedded in parafﬁn, sliced
into 5-lm-thick sections. H&E and Masson’s trichrome staining
were performed to monitor lipid accumulation and collagen depo-
sition, respectively. For smooth muscle alpha-actin (a-SMA) detec-
tion, immunohistochemical analysis was described previously [24].
Brieﬂy, the deparafﬁnized liver sections were treated with 5% non-
fat milk to inactivate endogenous peroxidase, and incubated with
primary antibody (a-SMA) at 4 C overnight. Then slides were
washed and incubated at room temperature with biotinylated goat
anti-rabbit antibody. Final incubation was carried out for 1 h with
an avidin–horseradish peroxidase complex, and positive reactions
were visualized with DAB.
2.4. Quantitative real-time PCR
Total RNA from liver sample was extracted using Trizol (Invitro-
gen, CA) according to the manufacturer’s instruction. Reverse tran-
script reaction was carried out by KeyGene reverse transcript
enzyme according to the manufacturer’s protocol. The real-time
PCR reaction was carried out on ABI 7300 real-time PCR system
with cDNA sample and ampliﬁed in a 20 ll reaction volume con-
taining 1 SYBR Green PCR master mix (Applied Biosystems, CA).
The primers used in this work were shown in Table 1. Relativeemistry of the livers from control and ﬁbrosis mice after twice-a-week injection of
rosis group (B) whereas in control mice, little collagen was detected (A). For a-SMA
n ﬁbrosis mice, markedly HSC activation was observed (D). Original magniﬁcation
P. Chen et al. / FEBS Letters 584 (2010) 1597–1601 1599expression in comparison with Gapdh was calculated by the com-
parative CT method.
2.5. Data analysis and statistics
Results were expressed as mean ± S.E.M. The single cosinor
method was used for analysis of circadian rhythm [10,25], and
the cosine function equation was as follows: Y (t) =M +
Acos(xt + u). The rhythm characteristics estimated by this method
included the mesor (middle value of the ﬁtted cosine representing
a rhythm-adjusted mean), the amplitude (half the difference
between the minimum and maximum of the ﬁtted cosine func-
tion), and the acrophase (time of peak value in the ﬁtted cosine
function). A probability value determined from comparison of
residuals, before and after cosine curve ﬁtting, of 60.05 indicated
detection of a rhythm. Rhythm characteristics (mesor, amplitude,
and acrophase) were compared between groups by unpaired Stu-
dent t test and differences were considered signiﬁcant at P < 0.05.
3. Results
3.1. Hepatic ﬁbrosis and hepatic stellate cell activation were observed
after chronic CCl4 treatment
To conﬁrm hepatic ﬁbrosis was induced in CCl4 treated mice,
Masson’s trichome staining was performed to show the hepatic
collagen deposition. As shown in Fig. 1A and B, the control mice in-
jected with oil only displayed limited collagen staining whereas in
CCl4 group, mice developed ﬁbrous septa around the centrilobular
and formed bridging ﬁbrosis. Because activated hepatic stellate cell
(HSC) was the main source of collagen, and a-SMA expression was
the key marker of HSC activation [11], we monitored the HSC acti-0 4 8 12 16 20 24
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Fig. 2. Circadian expression of clock genes in control and ﬁbrosis mice. Levels of mR
expressions of Bmal1 and Per1 were attenuated and the mesors in the expressions of Clo
were signiﬁcantly delayed. Circadian rhythm of Cry2 expression was lost in ﬁbrosis grouvation using a-SMA immunohistochemistry in control and CCl4
group. As shown in Fig. 1C and D, in control group, a-SMA staining
was restricted to vessel walls while in CCl4 group a-SMA-positive
area was observed around the centrolobular and inﬁltrated the lob-
ule. These results demonstrated that liver ﬁbrosis was successfully
established in CCl4 treated group.
3.2. Altered hepatic clock genes expression in liver ﬁbrosis mice
The core components of clockwork consists of a transcriptional
feedback loop in which clock and brain and muscle Arnt-like pro-
tein 1 (Bmal1) play the positive regulation role while period
(Per) and cryptochrome (Cry) act as the negative regulators [1,2],
thus it mainly involves in six members, Bmal1, Clock, Per1, Per2,
Cry1 and Cry2 [4]. Normally, most of these genes exhibit circadian
expression pattern in both primary circadian oscillator (SCN) and
peripheral tissues including liver [3]. To investigated possible ef-
fects of hepatic ﬁbrogenesis on clock genes expression, we ana-
lyzed the hepatic diurnal expression of transcripts encoding
CLOCK, BMAL1, PER1, PER2, CRY1 and CRY2 in the control and
ﬁbrosis mice at ZT1, ZT5, ZT9, ZT13, ZT17, ZT21 (ZT0 corresponds
lights on and ZT12 to light off). As shown in Fig. 2, statistical anal-
ysis with the single cosinor method revealed that highly signiﬁcant
24-h variations in the expression of almost all clock genes exam-
ined were observed in control and ﬁbrosis mice. Table 2 showed
the mesors of Clock and Per1 were signiﬁcantly higher in ﬁbrosis
mice. The amplitudes of the variations in Bmal1 and Per1 were sig-
niﬁcantly lower in ﬁbrosis group. Additionally, the acrophases of
Clock, Per1 and Cry1 were delayed in ﬁbrosis mice compared with
control mice. Especially, the rhythmic expression of Cry2 was to-
tally disrupted with dramatically reduced during day time (ZT1,
ZT5 and ZT9) in ﬁbrosis animals. Notably, there were no signiﬁcant0 4 8 12 16 20 24
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NA were determined by quantitative real-time PCR. The amplitudes of circadian
ck and Per1 were increased. Acrophases for the expressions of Clock, Per1 and Cry1
p. Data represent means ± S.E.M. (n = 5–6).
Table 2
Circadian rhythmic parameters of clock gene transcriptions in control and liver
ﬁbrosis mice.
Gene Mesor Amplitude Acrophase ZT (h)
Control
Bmal1 0.30 ± 0.03 0.35 ± 0.03 23.15 ± 0.07
Clock 0.54 ± 0.06 0.26 ± 0.04 0.52 ± 0.09
Per1 5.36 ± 0.56 5.38 ± 0.49 12.23 ± 0.15
Per2 12.64 ± 4.25 13.91 ± 4.71 14.06 ± 0.27
Cry1 0.70 ± 0.09 0.48 ± 0.05 19.43 ± 0.12
Cry2 0.69 ± 0.10 0.24 ± 0.04 6.00 ± 0.49
PPARa 1.13 ± 0.23 0.85 ± 0.22 8.90 ± 0.02
POR 0.63 ± 0.11 0.24 ± 0.06 12.90 ± 0.39
Fibrosis
Bmal1 0.31 ± 0.05 0.22 ± 0.04* 0.39 ± 0.12
Clock 0.76 ± 0.10* 0.19 ± 0.04 4.39 ± 0.32**
Per1 12.78 ± 2.29** 3.50 ± 0.43* 14.27 ± 0.62**
Per2 12.72 ± 3.60 11.78 ± 4.16 15.18 ± 0.81
Cry1 0.71 ± 0.10 0.44 ± 0.05 21.48 ± 0.69**
Cry2 – – –
PPARa 0.41 ± 0.10* 0.12 ± 0.08* 9.67 ± 2.58
POR 0.37 ± 0.07* 0.04 ± 0.002* 11.27 ± 2.46
Data represent means ± S.E.M., *P < 0.05, **P < 0.01 vs. control group.
1600 P. Chen et al. / FEBS Letters 584 (2010) 1597–1601differences in rhythmic parameters of Per2 in both groups. Collec-
tively, these data indicated that the expression of hepatic clock
genes has been altered in the ﬁbrosis mice.
3.3. Attenuated rhythmic mRNA expression of PPARa and POR in
ﬁbrotic liver
Altered circadian genes expression implied that a series of
downstream clock-controlled genes would change their expression
rhythm. Then we examined the expressions of PPARa and POR in
ﬁbrotic liver by quantitative RT-PCR. As shown in Fig. 3, highly sig-
niﬁcant circadian rhythms in the expressions of PPARa and POR
were observed in control group, however, in ﬁbrosis animals, the
mesors of both PPARa and POR were signiﬁcantly lower and the
amplitudes of both genes were markedly attenuated (Table 2).
Therefore, these data revealed that in ﬁbrotic liver, the impaired
clock genes expression resulted in disrupted clock-regulated genes
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Fig. 3. Hepatic expression of PPARa and POR in control and ﬁbrosis mice. Levels of
mRNA were determined by real-time quantitative PCR. The mesors and amplitudes
of the expression of both genes were dramatically attenuated in ﬁbrosis mice. Data
represent means ± S.E.M. (n = 5).4. Discussion
In the present study, we compared the liver clock genes expres-
sion in control and ﬁbrosis mice to provide direct evidence that
molecular clockwork was disrupted in ﬁbrotic liver. The amplitude
of circadian expression of clock genes (Clock, Bmal1, Per1, Cry1 and
Cry2) were signiﬁcantly changed in ﬁbrotic livers compared with
control livers, except for Per2. Martino et al. showed that some
clock gene rhythms in cardiac hypertrophic mice could remain un-
changed and they suggested that rhythmicity was an important
contributing mechanism to compensatory hypertrophy [26]. In this
work, notably, Per2 expression rhythm was not obviously shifted
and altered in ﬁbrotic livers, which may implied that the rhythmic
expression of Per2 gene could be an important contribution mech-
anism to liver ﬁbrosis development. In our previous observation,
mice deﬁcient in Per2 exhibited markedly sensitive to chronic
CCl4 treatment compared with WT mice [27]. Hence, Per2 gene
played a protective role in chemical-induced liver failure.
With alterations of the rhythmic expression of clock genes in ﬁ-
brotic liver, consequently, some clock-controlled genes, such as
PPARa and POR, lost their circadian expression rhythm with a se-
verely declined mRNA levels. PPARa and POR were both clock-reg-
ulated genes and exhibited circadian expression pattern in liver
[28,29]; PPARa had been shown involving in many physiological
processes such us lipid metabolism, inﬂammatory responses, oxi-
dative stress and controls of cell cycle [30]. The cytochrome
P450s belonged to a superfamily that played a central role in the
detoxiﬁcation of xenobiotics, as well as in the metabolism of
endogenous compounds such as steroids, fatty acids, prostaglan-
dins and leukotrienes [31]. POR was a very important factor in reg-
ulating the activity of cytochrome P450s and the downstream
processes [31]. Thus, both of them were upstream compounds
and we thought that their expression might reﬂect the metabolism
status in liver. It was reported that PPARa deﬁcient mice showed
defect in lipid metabolism with enhanced hepatic lipid accumula-
tion [32]. In this work, the expression of PPARa was dramatically
reduced in ﬁbrotic livers compared with control livers; liver stea-
tosis was also correlated with liver ﬁbrosis [33]. POR knockout
mice exhibited a profound decrease in all hepatic microsomal
P450 functions and compromised drug metabolism [31]. In addi-
tion, Barreiro et al. had provided a piece of evidence in support
of a correlation between liver ﬁbrosis and impaired drug metabo-
lism [34]. Therefore, changes of many physiological parameters
(e.g. lipid and drug metabolism) in ﬁbrosis animals might be attrib-
uted by the impaired PPARa and POR expression.
In conclusion, our observations demonstrate that liver ﬁbrogen-
esis change the hepatic circadian expression of clock genes. Further
study is to explore the detail about how liver ﬁbrogenesis affects
the clock genes expression and how does the altered clock genes
expression affect the circadian physiology in liver cirrhosis.
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